Correlation Between Scpharmaceuticals and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Scpharmaceuticals and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Anebulo Pharmaceuticals.
Diversification Opportunities for Scpharmaceuticals and Anebulo Pharmaceuticals
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Scpharmaceuticals and Anebulo is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Anebulo Pharmaceuticals
Given the investment horizon of 90 days Scpharmaceuticals is expected to generate 0.82 times more return on investment than Anebulo Pharmaceuticals. However, Scpharmaceuticals is 1.22 times less risky than Anebulo Pharmaceuticals. It trades about -0.14 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about -0.19 per unit of risk. If you would invest 443.00 in Scpharmaceuticals on August 30, 2024 and sell it today you would lose (69.00) from holding Scpharmaceuticals or give up 15.58% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Scpharmaceuticals vs. Anebulo Pharmaceuticals
Performance |
Timeline |
Scpharmaceuticals |
Anebulo Pharmaceuticals |
Scpharmaceuticals and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Scpharmaceuticals and Anebulo Pharmaceuticals
The main advantage of trading using opposite Scpharmaceuticals and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
Anebulo Pharmaceuticals vs. Bright Minds Biosciences | Anebulo Pharmaceuticals vs. HP Inc | Anebulo Pharmaceuticals vs. Intel | Anebulo Pharmaceuticals vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |